RaloxifeneCDK4/6InhibitorsBrachytherapyNeoplasmTriplePositiveBreastCancerEGFR(epidermalgrowth factorreceptor)BOCABilateralProphylacticMastectomyCachexiaCheckpointInhibitorGuaranteedRenewableInsuranceAntiemeticLymphNodeStatusGeneMutationDimplingGermlineMutationAdenocarcinomaApoptosisAdvocacyKappaEpsilonMRINodeNegativeCystBreastCancerLCISBreastTomosynthesisFISHLumpectomyTamoxifenPARPInhibitorsChemotherapyPhysicalactivity mayreduce therisk of breastcancersER-MetastasisOvarianSuppressionACChemotherapyOligometastasesMammography is alow-dose X-rayexamination thatcan detect breastcancer two yearsbefore it is largeenough to be feltMegestrolAcetateCAMRelapseKi-67RateRADImmunotherapyAromataseInhibitorsAyurvedaLapatinibSelf-examinationBiopsyMultifocalTumorsTumorGradeFamilyHistoryAlcohol intakeof more thantwo drinks perday is a riskfactor for breastcancerLymphoscintigraphyDown-StagingNodePositiveCyclophosphamideWomen ages40+ shouldhave a clinicalbreast examat least yearlyMorpheaGeneticPredispositionHER-2ProgestinWomen ages20-39 yoshould have aclinical breastexam at leastevery 3 years.PrecisionMedicinePalpationStagingMastectomyAdjuvantTherapyEstrogenSERMFlowCytometryCapecitabineGenomicTestingAngiogenesisIntraductalPapillomaER+PaclitaxelHerceptinHormoneReplacementTherapyCytotoxicGailModelDoseDenseTherapyCytostaticBI-RADSEstimated 2,150 menwill be diagnosedwith breast cancerand approximately410 will die each yearMultimodalityTherapy1 in 8womenLumpAntibodyTherapyBRCAGeneDoxorubicinTripleNegativeBreastCancerPalbociclibMastodyniaBevacizumabBreast cancer isthe leading causeof death in womenbetween the agesof 40 and 55AbsoluteRiskDocetaxelCMFChemotherapyInvasiveBreastCancerGeneticCounselingmTORInhibitorsAfrican-Americanwomen have a lowerchance of breastcancer overall, butthey are 40% morelikely to die frombreast cancer thanwhite womenCalcificationsPI3KinaseInhibitorsFor every 1,000screeningmammogramsperformed, aboutfive breast cancersare detected.5-FluorouracilRadiotherapyFibroadenomaAnastrozolePhyllodesTumorMethotrexatePagetDiseasePathologicResponseDefinitiveSurgeryIn-situCarcinomaECOGScoreTyrosine-KinaseInhibitorExcisionalBiopsyHormoneReceptorStatusCo-survivorEstradiolNeoadjuvantTherapyChemopreventionAlopeciaAxillarySamplingRaloxifeneCDK4/6InhibitorsBrachytherapyNeoplasmTriplePositiveBreastCancerEGFR(epidermalgrowth factorreceptor)BOCABilateralProphylacticMastectomyCachexiaCheckpointInhibitorGuaranteedRenewableInsuranceAntiemeticLymphNodeStatusGeneMutationDimplingGermlineMutationAdenocarcinomaApoptosisAdvocacyKappaEpsilonMRINodeNegativeCystBreastCancerLCISBreastTomosynthesisFISHLumpectomyTamoxifenPARPInhibitorsChemotherapyPhysicalactivity mayreduce therisk of breastcancersER-MetastasisOvarianSuppressionACChemotherapyOligometastasesMammography is alow-dose X-rayexamination thatcan detect breastcancer two yearsbefore it is largeenough to be feltMegestrolAcetateCAMRelapseKi-67RateRADImmunotherapyAromataseInhibitorsAyurvedaLapatinibSelf-examinationBiopsyMultifocalTumorsTumorGradeFamilyHistoryAlcohol intakeof more thantwo drinks perday is a riskfactor for breastcancerLymphoscintigraphyDown-StagingNodePositiveCyclophosphamideWomen ages40+ shouldhave a clinicalbreast examat least yearlyMorpheaGeneticPredispositionHER-2ProgestinWomen ages20-39 yoshould have aclinical breastexam at leastevery 3 years.PrecisionMedicinePalpationStagingMastectomyAdjuvantTherapyEstrogenSERMFlowCytometryCapecitabineGenomicTestingAngiogenesisIntraductalPapillomaER+PaclitaxelHerceptinHormoneReplacementTherapyCytotoxicGailModelDoseDenseTherapyCytostaticBI-RADSEstimated 2,150 menwill be diagnosedwith breast cancerand approximately410 will die each yearMultimodalityTherapy1 in 8womenLumpAntibodyTherapyBRCAGeneDoxorubicinTripleNegativeBreastCancerPalbociclibMastodyniaBevacizumabBreast cancer isthe leading causeof death in womenbetween the agesof 40 and 55AbsoluteRiskDocetaxelCMFChemotherapyInvasiveBreastCancerGeneticCounselingmTORInhibitorsAfrican-Americanwomen have a lowerchance of breastcancer overall, butthey are 40% morelikely to die frombreast cancer thanwhite womenCalcificationsPI3KinaseInhibitorsFor every 1,000screeningmammogramsperformed, aboutfive breast cancersare detected.5-FluorouracilRadiotherapyFibroadenomaAnastrozolePhyllodesTumorMethotrexatePagetDiseasePathologicResponseDefinitiveSurgeryIn-situCarcinomaECOGScoreTyrosine-KinaseInhibitorExcisionalBiopsyHormoneReceptorStatusCo-survivorEstradiolNeoadjuvantTherapyChemopreventionAlopeciaAxillarySampling

BOCA Bingo - Call List

(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
  1. Raloxifene
  2. CDK4/6 Inhibitors
  3. Brachytherapy
  4. Neoplasm
  5. Triple Positive Breast Cancer
  6. EGFR (epidermal growth factor receptor)
  7. BOCA
  8. Bilateral Prophylactic Mastectomy
  9. Cachexia
  10. Checkpoint Inhibitor
  11. Guaranteed Renewable Insurance
  12. Antiemetic
  13. Lymph Node Status
  14. Gene Mutation
  15. Dimpling
  16. Germline Mutation
  17. Adenocarcinoma
  18. Apoptosis
  19. Advocacy
  20. Kappa Epsilon
  21. MRI
  22. Node Negative
  23. Cyst
  24. Breast Cancer
  25. LCIS
  26. Breast Tomosynthesis
  27. FISH
  28. Lumpectomy
  29. Tamoxifen
  30. PARP Inhibitors
  31. Chemotherapy
  32. Physical activity may reduce the risk of breast cancers
  33. ER-
  34. Metastasis
  35. Ovarian Suppression
  36. AC Chemotherapy
  37. Oligometastases
  38. Mammography is a low-dose X-ray examination that can detect breast cancer two years before it is large enough to be felt
  39. Megestrol Acetate
  40. CAM
  41. Relapse
  42. Ki-67 Rate
  43. RAD
  44. Immunotherapy
  45. Aromatase Inhibitors
  46. Ayurveda
  47. Lapatinib
  48. Self-examination
  49. Biopsy
  50. Multifocal Tumors
  51. Tumor Grade
  52. Family History
  53. Alcohol intake of more than two drinks per day is a risk factor for breast cancer
  54. Lymphoscintigraphy
  55. Down-Staging
  56. Node Positive
  57. Cyclophosphamide
  58. Women ages 40+ should have a clinical breast exam at least yearly
  59. Morphea
  60. Genetic Predisposition
  61. HER-2
  62. Progestin
  63. Women ages 20-39 yo should have a clinical breast exam at least every 3 years.
  64. Precision Medicine
  65. Palpation
  66. Staging
  67. Mastectomy
  68. Adjuvant Therapy
  69. Estrogen
  70. SERM
  71. Flow Cytometry
  72. Capecitabine
  73. Genomic Testing
  74. Angiogenesis
  75. Intraductal Papilloma
  76. ER+
  77. Paclitaxel
  78. Herceptin
  79. Hormone Replacement Therapy
  80. Cytotoxic
  81. Gail Model
  82. Dose Dense Therapy
  83. Cytostatic
  84. BI-RADS
  85. Estimated 2,150 men will be diagnosed with breast cancer and approximately 410 will die each year
  86. Multimodality Therapy
  87. 1 in 8 women
  88. Lump
  89. Antibody Therapy
  90. BRCA Gene
  91. Doxorubicin
  92. Triple Negative Breast Cancer
  93. Palbociclib
  94. Mastodynia
  95. Bevacizumab
  96. Breast cancer is the leading cause of death in women between the ages of 40 and 55
  97. Absolute Risk
  98. Docetaxel
  99. CMF Chemotherapy
  100. Invasive Breast Cancer
  101. Genetic Counseling
  102. mTOR Inhibitors
  103. African-American women have a lower chance of breast cancer overall, but they are 40% more likely to die from breast cancer than white women
  104. Calcifications
  105. PI3 Kinase Inhibitors
  106. For every 1,000 screening mammograms performed, about five breast cancers are detected.
  107. 5-Fluorouracil
  108. Radiotherapy
  109. Fibroadenoma
  110. Anastrozole
  111. Phyllodes Tumor
  112. Methotrexate
  113. Paget Disease
  114. Pathologic Response
  115. Definitive Surgery
  116. In-situ Carcinoma
  117. ECOG Score
  118. Tyrosine-Kinase Inhibitor
  119. Excisional Biopsy
  120. Hormone Receptor Status
  121. Co-survivor
  122. Estradiol
  123. Neoadjuvant Therapy
  124. Chemoprevention
  125. Alopecia
  126. Axillary Sampling